Stockreport

RenovoRx Highlights Promising Pre-Clinical Data Abstract: TAMP™ Therapy Platform Offers Potential to Improve Localized and Targeted Drug Delivery [Yahoo! Finance]

RenovoRx, Inc.  (RNXT) 
PDF Business Wire Thu, February 13, 2025 at 2:00 PM GMT+1 10 min read In This Article RNXT Pre-Clinical Data Recently Presented at the SIO 2025 Annual Conference [Read more]